CONMED CORP shareholders Q3 2023

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 273 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
DUALITY ADVISERS, LP 7,322$738,4240.09%
Prudent Man Advisors, LLC 2,154$217,2310.09%
SEI INVESTMENTS CO 470,774$47,477,6410.08%
Congress Wealth Management LLC / DE / 40,101$4,044,2640.08%
EULAV Asset Management 22,700$2,289,2950.08%
Zions Bancorporation, N.A. 9,370$944,9650.08%
TUDOR INVESTMENT CORP ET AL 78,426$7,909,2620.08%
BNP Paribas Asset Management Holding S.A. 249,371$25,1490.08%
CONNABLE OFFICE INC 5,153$519,6800.07%
Capital Research Global Investors 2,467,112$248,808,2450.07%
LORD, ABBETT & CO. LLC 182,063$18,3610.07%
Bayesian Capital Management, LP 6,021$607,2180.07%
GAMCO INVESTORS, INC. ET AL 57,550$5,803,9180.07%
Portman Square Capital LLP 26,421$2,664,5580.07%
FORA Capital, LLC 7,293$735,4990.06%
Trexquant Investment LP 25,130$2,534,3610.06%
Teza Capital Management LLC 6,650$670,6530.06%
VOYA INVESTMENT MANAGEMENT LLC 478,414$48,248,0530.06%
abrdn plc 235,192$23,719,1130.06%
GLENMEDE TRUST CO NA 104,001$10,488,5000.06%
External links

This page lists CONMED CORP's shareholders in Q3 2023. To view CONMED CORP's shareholder history, click here.